Genomic imprinting regulates the expression of a group of genes monoallelically expressed in a parent-oforigin specific manner. Allele-specific DNA methylation occurs at differentially methylated regions (DMRs) of these genes. We have previously shown that in vitro fertilization and embryo culture result in methylation defects at the imprinted H19-Igf2 locus at the blastocyst stage. The current study was designed to evaluate the consequences of these manipulations on genomic imprinting after implantation in the mouse. Blastocysts were produced following three experimental conditions: (i) embryos maintained in culture medium after in vivo fertilization or (ii) in vitro fertilization and (iii) a control group with embryos obtained after in vivo fertilization and timed mating. Blastocysts were all transplanted into pseudopregnant females. Embryos and placentas were collected on day 10.5 of development. DNA methylation patterns of the H19, Igf2, Igf2r and Dlk1 -Dio3 DMRs were analyzed by quantitative pyrosequencing. In contrast to blastocyst stage, methylation profiles were normal both in embryonic and placental tissues after in vitro fertilization and culture. Expression of a selected set of imprinting genes from the recently described imprinted gene network (IGN) (including Igf2 and H19) was analyzed in placental tissues by quantitative RT -PCR. Placentas obtained after in vitro fertilization and embryo culture displayed significantly disturbed levels of H19 and Igf2 mRNA, as well as of most other genes from the IGN. As embryos were phenotypically normal, we hypothesize that the modulation of a coordinated network of imprinted genes results in a compensatory process capable of correcting potential dysfunction of placenta.
INTRODUCTION
Children born from assisted reproductive technologies (ART) account for 2.2% of all births in the USA and 1.6% in the UK (1, 2) . Although the great majority of these children are in good health, a small but worrying percentage suffers from a variety of morbid congenital problems and has twice the rate of major birth defects compared with naturally conceived offspring (3) . This risk persists even after adjusting for increased maternal age and increased incidence of multiple gestations after ART. Birth defects include chromosomal abnormalities, musculoskeletal and cardiovascular defects, and low birth weight (4) . Furthermore, several reports suggested that in vitro fertilization (IVF) increases the risk of diseases caused by aberrant genomic imprinting such as Beckwith-Wiedemann syndrome (5-9), Angelman syndrome (8, 10, 11) and Silver -Russell syndrome (12, 13) . Imprinted genes are expressed monoallelically in a parent-of-origin specific manner. These genes are generally located in clusters, epigenetically marked by DNA methylation on key regulatory sequences (differentially methylated regions, DMRs), by histone modifications (acetylation/deacetylation and methylation) and sometimes associated with antisense RNAs (14 -16) . The allele-specific methylation of primary DMRs or imprinting control centers (ICR) such as the H19 DMR occurs in germ cells and provides a heritable 'memory' that is maintained throughout fertilization and embryo development. This differential methylation is preserved during preimplantation development, despite genome-wide changes in global DNA methylation occurring at these early stages (17) . In somatic cells, the other DMRs considered as secondary DMRs are de novo methylated and the allele-specific methylation status is maintained throughout cell division.
It has been previously demonstrated that IVF disturbs DNA methylation patterns at specific locations of the H19 -Igf2 locus in individual mouse blastocysts and that epigenetic changes were influenced by culture medium (18) . These data as well as data from others (19, 20) suggest that the H19 -Igf2 locus could be considered as a relevant biomarker of epigenetic alterations induced by environmental conditions. However, the temporal evolution of these defective DNA methylation/gene expression patterns during the developmental process is so far unclear. Could the embryos exposed to various environmental conditions restore correct DNA methylation and expression patterns of H19 and Igf2 genes at the post-implantation stage? The current study was designed to examine the effects of two different embryo culture media associated or not with in vitro fertilization on subsequent normal post-implantation development (Fig. 1) . We studied methylation profiles of the H19 and Igf2 DMRs, as well as of the Igf2r and Dlk1 -Dio3 DMRs in embryos and placentas collected at 10.5 days of development. The expression levels of 19 genes belonging to the imprinted gene network (IGN) involved in embryonic growth, were also analyzed in placentas (21, 22) . We were able to show that the collected embryos display a phenotypically normal development after in vitro fertilization and different culture procedures. They also present the expected methylation profile for all DMRs both in placenta and embryos without significant alteration. Unexpectedly, expression of H19 and Igf2 was up-regulated in the placenta from manipulated embryos when compared with the control group. A correlated regulation of several other imprinted genes was also observed. We hypothesize that this modulation of several genes from the IGN in a coordinated fashion could constitute a major compensatory mechanism enabling the developing fetus to cope with changing or abnormal environment.
RESULTS
Mouse blastocyts were produced following three different experimental conditions: group A after in vivo fertilization and development (as control group), group B after in vivo fertilization and in vitro development and group C after both in vitro fertilization and development. Group C is the group in which the different steps of human ART are most closely mimicked. All embryos were transferred to the uteri of pseudopregnant females. Embryos and placentas were then collected from recipient females at day 10.5 of development (Fig. 1) . Upon close observation, all embryos were at the correct developmental stage according to the Theiler criteria (23) and were collected. However, some resorption sites were observed. The number of resorption sites was significantly higher in the manipulated groups [with embryo culture (47.8%) or in vitro fertilization and embryo culture (64.1%)] when compared with the control group (18.5%; P , 0.05) suggesting that embryos died at an early stage of development (24) . In vivo fertilization and preimplantation development (group A); in vivo fertilization and in vitro preimplantation embryo development (group B); in vitro fertilization and preimplantation embryo development (group C). Embryo culture was performed in two different culture media: M16 and G1/G2. The timeline in hours (h) is relative to the hCG injection (0 h). For all groups, the blastocysts were transferred in pseudopregnant d3.5 F1 females.
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Methylation analysis of four DMRs of the H19-Igf2 locus in embryos and placentas from control group
We analyzed the methylation levels of 39 CpGs of the Igf2 DMR0, DMR1 and DMR2 and of the 30 CpGs located in the four CCCTC-binding factor (CTCF) binding sites of the H19 DMR (Fig. 2) . This was first done on genomic DNA from control embryos and placentas (group A) collected at day 10.5 of development. For the Igf2 DMR0, the mean methylation level was 87.2 + 0.8% in embryo and 69.4 + 1.6% in placental DNA (Fig. 3A) . This level was significantly decreased in the placenta compared with embryos (P , 0.001). No significant difference of the methylation status was found between embryonic and extra-embryonic tissues for the Igf2 DMR1 (39.0 + 1.6% versus 41.4 + 1.5%, respectively) (Fig. 3B) . Finally, the mean methylation was significantly reduced in embryos compared with placentas for the Igf2 DMR2 (Fig. 3C) . The average methylation was 29.6 + 0.6 and 44.4 + 1.2% for the first 13 CpGs and 13.3 + 0.4 and 36.9 + 1.1% for the next CpGs in embryos and placentas, respectively, demonstrating a significant hypomethylation of the DMR2 (P , 0.001) in embryos at day 10.5 of development.
For the H19 DMR, a similar mean methylation level was observed for the four CTCF binding sites in embryos and placentas (47.6 + 0.4 versus 47.1 + 0.6%, Fig. 3D ). However, three placentas of 21 without morphological abnormalities presented a significant hypomethylation at CTCF binding sites 3 and 4, whereas CTCF biding sites 1 and 2 displayed a normal methylation level. The three counterpart embryos displayed a normal methylation pattern of all CpGs.
Methylation analysis of the H19 -Igf2 locus in embryos and placentas from experimental groups
The methylation levels of the four DMRs in DNA from experimental groups B and C were compared with the control group (Fig. 4) .
For the Igf2 DMR0, embryos from group B and C presented a mean methylation level of 87.0 + 1.2 and 86.3 + 1.5% compared with 75.8 + 1.7 and 69.9 + 1.7% in placental DNA in both culture media (Fig. 4) . These results did not differ from the control group A in which, as mentioned above, the DMR0 methylation level was significantly lower in placenta compared with embryo. No significant difference was observed neither for embryos from groups A, B and C in the two other DMRs (DMR1: 39.0 + 1.7%, 41.6 + 1.8%, 42.9 + 1.8% and DMR2: 21.9 + 0.5%, 20.9 + 0.6%, 22.4 + 0.8%, respectively, t-test, P . 0.05) nor for the placentas (DMR1: 41.9 + 1.7%, 43.5 + 1.8% and 41.4 + 1.5%, DMR2: 45.3 + 1.3%, 42.4 + 0.8% and 40.7 + 0.8%, respectively, t-test, P . 0.05). This suggests that the culture media has no influence on the methylation profile.
Comparable mean methylation levels of H19 DMR were also observed in embryos of groups A, B and C (58.7 + 0.6%, 54.6 + 0.9%, 55.5 + 1.0%, respectively) (Fig. 4) . However, a decrease of 10% was observed for CTCF binding site 1, 3 and 4 in placentas from group B and C compared with placentas from control group. When using pyrosequencing analysis, only differences in methylation levels above 5% are considered as significant (25) . However, it is not clear whether this placental hypomethylation represents an important alteration, since a high individual variability of methylation level was observed in all groups (Fig. 3D) .
In addition, we analyzed the methylation levels of two other DMRs, the paternally methylated Dlk1 -Dio3 imprinting control region (13 CpGs) and the maternally methylated Igf2r DMR (12 CpGs). For the Igf2r DMR, comparable methylation levels were found in embryos and placentas in control group A (52.7 + 0.9 and 53.6 + 1.1%, respectively, t-test, P . 0.05; Fig. 4 ) and no difference was observed between A, B and C experimental groups. Additional analysis on Dlk1 -Dio3 imprinting control region confirmed the absence of methylation perturbation in groups B and C compared with the control group (data not shown).
Expression of the IGN
To extend our analysis, we compared the level of expression of H19 and Igf2 as well as of 17 other imprinted genes belonging to the previously described IGN which displays correlated expression during development (21, 22) , in placentas from groups A, B and C. This expressional analysis was performed using quantitative RT -PCR and geNorm quantification (26) . The relative expression levels in control placentas strongly differed between the 19 genes analyzed (Supplementary Material, Fig. S1 ). H19 was one of the most highly expressed genes compared with the other genes of the IGN.
Strikingly, a large number of these genes (more than 13 of 19) had highly modified levels of expression in placentas from groups B and C compared with control group A (Fig. 5) .
Among the maternally expressed imprinted genes, Cdkn1c, Gtl2, H19 and Rian were significantly up-regulated, whereas Dcn and Gatm were down-regulated in both groups B and C compared with control group A (Fig. 5 ). Grb10 expression 
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was mostly unchanged. Interestingly, Igf2r was highly up-regulated in group C and unchanged in group B. Six of 10 paternally expressed imprinted genes (Dlk1, Igf2, Nnat, Peg3, Slc38a4 and Zac1) were found significantly up-regulated in groups B and C when compared with control group A. Rtl1 and Sgce were also up-regulated but only in group C. Ndn expression levels were mostly unchanged, whereas Mest was found down-regulated in group B. Interestingly, contrary to maternally expressed genes, none of the paternally expressed genes were down-regulated in both groups. Increased expression levels of more than 2-fold were observed for six imprinted genes in the placentas from group B (Gtl2, H19, Dlk1, Igf2, Nnat and Peg3) and nine imprinted genes in the placentas from group C (Gtl2, H19, Igf2r, Dlk1, Igf2, Nnat, Peg3, Sgce and Slc38a4) compared with the control group. In addition, we observed that the expression patterns were not significantly different according to the culture medium.
No difference was found upon observation of the placenta morphology from the three experimental groups. We also evaluated the expression levels of decidual markers such as Gabrp, Enpp3 and Kcne4. These were found unchanged, suggesting a conserved proportion of maternal decidua versus fetal compartment in placentas from all experimental groups (data not shown).
DISCUSSION
The aim of our study was to determine whether ART manipulations result in an altered methylation status of the H19 -Igf2 locus. We also focused on the expression of imprinted Figure 4 . Methylation levels of the four DMRs within the H19-Igf2 locus and the Igf2r DMR2 in embryos and placentas produced by assisted reproductive technologies (groups B and C). Methylation levels of Igf2 DMR0, DMR1 and DMR2 of the four CTCF binding sites of H19 ICR and Igf2r DMR2 in genomic DNA from embryos and placentas at day 10.5 of development after transfer of embryos obtained after in vivo fertilization and in vitro preimplantation embryo development (group B) and after in vitro fertilization and preimplantation embryo development (group C) were compared with the control group (group A). Data are presented as mean + SD for the methylation level of each DMR and each CTCF binding site. Significant P-values are indicated (P , 0.05, Student's t-test) by asterisks.
genes belonging to the recently described IGN in post-implantation embryos and placentas at day 10.5 of development. The H19 and Igf2 genes were chosen for their implication in the regulation of feto-placental growth (27 -29) and in the pathogenesis of imprinting disorders found in humans (6) . In mouse preimplantation embryos, H19 imprinting appears to be more sensitive to in vitro manipulations and culture medium than other imprinted genes as shown by us and others (18 -20,30 -32) . The epigenetic modifications induced at the early embryo stage could have deleterious effects on further post-implantation fetal and postnatal development. It was also recently shown that embryo transfer induced aberrant expression of imprinted genes in placenta (33) . In this study, we included embryo transfer for all groups and rather focused on in vitro fertilization and culture medium differences. We carried out the first systematic analysis of methylation profiles of 69 CpGs located within four DMRs involved in the imprinting control of the H19 -Igf2 locus, in embryos as well as in placentas. We added to this two other DMRs from the Igf2r and the Dlk1 -Dio3 genes. For this purpose, we used the pyrosequencing technology which was developed and validated for DNA methylation analysis of numerous individual samples on billions of molecules, thus providing excellent quantitative resolution (34) . In both embryonic and extra-embryonic tissues, the H19 DMR displayed a methylation level corresponding to the allele-specific methylation established during gametogenesis, conferring it the name of 'germline DMR'. Interestingly, Igf2 DMR2 methylation level in the embryo was significantly lower compared with DMR1 (20 versus 40%), whereas in placenta, the level was closer to 45% for both DMRs and displayed extensive variation at consecutive CpGs. The difference in methylation levels of DMR0 (87% in embryo versus 69% in placenta) is consistent with previous results, Figure 5 . Imprinted gene network expression in placentas from manipulated concepti (groups B and C). The expression levels of the nine maternally expressed imprinted genes (A) and the 10 paternally expressed imprinted genes (B) in placentas from in vivo or in vitro fertilization and preimplantation developed embryos in M16 and G1/G2 media (groups B and C) were presented relative to expression levels of control group (group A). Error bars indicate SEM. Asterisks indicate significant differences versus the group A, as indicated by non-parametric Kruskal-Wallis analysis of variance followed by post hoc paired comparisons.
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since DMR0 is methylated on both alleles in the fetus and only on the maternal allele in placenta (35) . The function of DMR0 is still unknown although it could be involved in a complex phenomenon of IGF2 imprinting loss occurring in human disease (36) . The data obtained in embryonic tissues are in close accordance with the model in which the DNA methylation patterns of the three DMRs (H19 DMR and Igf2 DMRs 1 and 2) are coordinately regulated by a hierarchy of these DMRs which in turn arises from long-range chromatin interactions (37) . Samples collected from the three experimental groups (A, B and C) displayed a similar pattern of methylation for all DMRs analyzed. In addition, no difference of the methylation status was found between a basic culture medium (M16) and a more complex sequential medium (G1/G2) containing methionine known to be involved in the methylation process. Nevertheless, we observed a higher individual variability in placenta compared with embryo in all groups, highlighting a specific epigenetic flexibility of placenta. As previously reported for the ICR2 locus on the distal chromosome 7, other epigenetic marks such as histone modifications could act as modulators of imprinting in placental tissue (38) .
In embryos obtained by in vitro development using Mus musculus castaneus females and C57BL/6J males, embryonic tissues preserved correct genomic imprints, whereas aberrant H19 imprinting was observed in some placentas (39) . However, in the reciprocal cross, both placentas and embryos showed appropriate imprint of the H19 gene under identical conditions. This genotype effect suggests that strainspecific modifiers might affect maintenance of the H19 imprint specifically in placental tissue. In our study, the methylation variability observed between concepti, all with a normal development according to their gestational stage could be explained by the formation of epigenetic mosaic embryos, probably at early stages of development.
Although our previous data had shown methylation differences for H19 on individual blastocysts, our present results show no major difference in the embryo methylation profile between control and experimental groups whatever the culture system used. This could suggest that the embryos with major epigenetic alterations do not implant or do not develop with a normal phenotype until 10.5 dpc. In contrast, embryos with minor epigenetic alterations would be able to restore an accurate methylation status at the H19 -Igf2 and other imprinted loci and present a normal post-implantation development. We demonstrate here that for implanted and normally developed embryos, H19 and Igf2 methylation was not affected although significant demethylations were observed for several CTCF binding sites of H19 DMR in the placenta. Our additional results concerning the Dlk1 -Dio3 and Igf2r DMRs confirm the appropriate epigenetic mark apposition in embryonic and placental tissues at E10.5. Our data support the hypothesis that the feto-placental development requires a completely restored epigenetic pattern in the embryo at least or that only embryos with epigenetic marks associated with functional imprinting have a satisfactory later embryonic development. This hypothesis is reinforced by the lower implantation rate of blastocysts and the higher number of resorption sites in the manipulated groups when compared with control group, reported by us and others (33) .
Placenta plays a crucial role in normal fetal development, and is a major organ for filtering effects coming from the outside environment to the fetus (40) . Therefore, we extended our investigation to a significant part of the IGN which has been recently described to be involved in embryonic and postnatal growth control (21, 22) . We demonstrated that in vitro fertilization and embryo culture modified expression of more than 15 of 19 genes in placentas of normally developed E10.5 embryos. Both maternally and paternally expressed imprinted genes are modified and mostly up-regulated. Only two maternally expressed genes were found down-regulated in placentas from all experimental groups and only one paternally expressed gene was down-regulated in placentas obtained after embryo culture.
A first group of genes including H19, Igf2, Igf2r, Zac1 and Slc38a4 was up-regulated in manipulated placentas and could be included in a regulatory pathway. Interestingly, H19 was strongly affected with a 2-fold increase in expression. Although H19 is highly expressed throughout embryogenesis (41, 42) , its role in placenta remains unknown. A recent study using transgenic mice with gain or loss of H19 expression suggests that H19 acts as a trans-regulator of the IGN in the embryo (22) . Inactivation of Igf2 induces intrauterine growth restriction of embryo closely associated to the decrease of placental functions (43, 44) . The lack of Igf2r results in embryonic overgrowth (43,45 -47) . In our manipulated placentas obtained after in vitro fertilization, these imprinted genes with reciprocal functions in fetal and placental growth were all up-regulated when compared with the control group. Whereas recent studies have shown that embryo transfer reduces and superovulation increases Igf2 mRNA levels (33,48), we found that embryo culture augmented these levels and that in vitro fertilization further exacerbated this effect. It is however difficult to compare these experiments and to conclude exactly which step of ART is involved in the modulation of Igf2 expression, because the aim of each study was different. Additional experiments including all variables (superovulation, transfer, IVF and culture) will be required to clarify the situation.
Zac1 directly regulates the H19 -Igf2 locus through binding to a shared enhancer (21) . As in vitro manipulations result in Zac1 overexpression, this gene may act as an activator of H19 and Igf2 expression observed in manipulated groups. An interesting result is the up regulation of Igf2r gene limited to placentas from group C. This raises the possibility of a regulation of the local IGF2 concentration with a para/autocrine activity in placental tissue. Indeed, IGF2R plays a major role in binding and regulating the tissue levels of IGF2. Finally, the paternally expressed Slc38a4 gene (located on chromosome 15) is imprinted in the placenta only and encodes a system A amino acid transporter (49) . It was recently suggested that the placenta could respond to fetal demand through crosstalk between the Igf2 gene and placental supply transporter genes such as the Slc38a4 gene (49) . Other imprinted genes (Peg3, Cdkn1c and Dlk1) involved in growth were also significantly up-regulated by in vitro manipulations. Peg3 on mouse chromosome 7 encodes a large Krüppel-type finger protein which is paternally expressed and associated with growth abnormalities (50) .
Cdkn1c, also on mouse chromosome 7, resides in the Beckwith -Wiedmann cluster and is involved in placental development (51) . Dlk1, paternally expressed on chromosome 12 encodes a member of Notch-Delta family of signaling molecules. It was recently demonstrated that the Gtl2 -Dlk1 locus contributes to mouse placentation (52) . In this locus, the paternally expressed Rtl1 is a retrotransposon-like gene. It appears essential for maintenance of the fetal capillaries, and both its loss and its overproduction cause late-fetal and/or neonatal lethality in mice (53) . Sgce located on chromosome 6 and paternally expressed, produces a member of the sarcoglycan family and a component of the transmembrane mediating cytoskeleton -extracellular matrix, highly expressed in the placenta (54, 55) . Gatm and Dcn, two maternally expressed genes not exclusively expressed in maternal decidua (56, 57) , were downregulated in manipulated groups. Gatm, on chromosome 2, encodes an L-arginine:glycine amidinotransferase which catalyzes the first step in creatine biosynthesis. Gatm levels could be critical for normal energy metabolism in the developing embryo (57) . A decreased expression of GATM and other imprinted genes has been recently described in human intrauterine growth restriction cases (58) . Decorin (Dcn) gene on mouse chromosome 10 is maternally expressed in placenta only (59) . It encodes a member of the proteoglycan family that can bind to TGF-b and to IGF1 receptor and may be involved in processes such as matrix assembly, cell adhesion, migration and proliferation (60) .
Our study has revealed the disrupted expression of numerous imprinted genes in the placenta after embryo manipulation. However, the methylation status of the DMRs from the H19, Igf2, Igf2r and Dlk1 genes is either similar to controls or very slightly modified. This would suggest that primary imprints are correctly established and maintained on these sequences and that it is the reading of these epigenetic marks which is altered, possibly at a post-implantation step. These alterations could include defective binding of transcription factors, modification of histone marks or of posttranscriptional regulations.
In summary, we observed an important and complex regulation of a large set of imprinted genes in manipulated groups. This illustrates how the placenta can respond to fetal demand signals through gene regulation involved in growth control and specific placental transport systems. As all embryos analyzed in this study were phenotypically and morphologically normal, this suggests that the regulation of IGN in placenta may adapt to environmental changes occurring during the first steps of development. An attractive hypothesis is that the biological function associated with the placental IGN is to participate in the control of normal fetal growth during post-implantation development through a fine-tuned compensatory regulation.
Previous data had suggested that affecting one gene (such as deletion of Zac1 or H19) resulted also in the attenuation of a phenotype through an adaptative process capable of modulating the expression of the genes from the IGN (21, 22) . From the experiments performed here, we can postulate that perturbing effects due to in vitro manipulation result in a counterbalance of the members of the IGN in the placenta. This could serve as a 'buffering system' and result in normal development of the embryo. Whether this general effect is due to one master gene which then affects a cascade of genes or whether several genes drive this developmental modulation is not clear.
Finally, our data on the consequences of ART manipulations in the mouse model at post-implantation stage moderate the risk of epigenetic abnormalities and appear more reassuring for the health of children born after ART compared with studies investigating preimplantation embryos. Imprinted genes appear to play a crucial role in adjusting the function of the placenta and obtaining a fairly normal embryonic development.
MATERIALS AND METHODS

Animals
Five-to six-week-old F1 (C57BL/6/CBA) females chosen for their good responsiveness to hormonal stimulation and eightto nine-week-old F1 males (Charles River Laboratories, L'Arbresle, France) were maintained in an animal facility at normal temperature (21 -238C) and 14 h light/10 h dark photoperiods with free access to water and food. Procedures for handling and experimentation followed ethical guidelines established by the Federation of European Laboratory Animal Science Associations.
Experimental design
Superovulated mice were divided into three different experimental groups (A, B and C). All females were superovulated. In group A, blastocysts were collected after in vivo fertilization and in vivo development. In group B, blastocysts were obtained after in vivo fertilization and in vitro development from one cell to blastocyst stage. In group C, blastocysts were obtained after in vitro fertilization and development.
The embryos from groups B and C were cultured either in M16 medium (Sigma-Aldrich, Lyon, France) (B M16) or in sequential G1/G2 medium (JCD Laboratories, Lyon, France) (C G1/G2).
Superovulation. Females were superovulated by intraperitoneal (i.p.) injection of 8 IU (0.1 ml) Pregnant Mare Serum Gonadotropin (PMSG, Chronogest; Intervet, Beaucouzé, France), followed 47 h later by an i.p. injection of 5 IU (0.1 ml) of human Chorionic Gonadotropin (hCG, Chorulon; Intervet).
In vitro fertilization and embryo culture. Thirteen hours post-hCG, cumulus -oocyte complexes were recovered from oviducts in M2 medium (Sigma-Aldrich) supplemented with 7 mg/ml of BSA (Sigma-Aldrich). After rinsing in M16 medium, cumulus -oocyte complexes were kept in the incubator (378C, 5.5% CO 2 in air) in 100 ml drops of M16 medium covered with paraffin oil (Vitrolife). Spermatozoa were collected from the cauda epididymis and capacitated for 90 min in M16 medium supplemented with 7 mg/ml of BSA at 378C and 5.5% CO 2 . Oocytes were inseminated 15 h post-hCG with 10 6 spermatozoa. Fertilized eggs (23 h post-hCG) as determined by the presence of two pronuclei were transferred to 30 ml drops of fresh medium covered with paraffin oil. To analyze the embryo culture medium effects, two different media were tested: the M16 medium and the sequential G1/G2 medium (61) containing amino acids. The embryo culture was conducted to blastocyst stage at 378C and 5.5% CO 2 . The culture medium was changed every day.
Collection of in vivo fertilized eggs. F1 females were mated individually with F1 males after hCG injection. The following morning, females were checked for vaginal copulation plug. One cell stage zygotes were retrieved by flushing the oviducts with M2 medium supplemented with BSA (7 mg/ml) 21-23 h post-hCG. After mechanical decoronization and washes, zygotes selected by the presence of two pronuclei were cultured in the two different culture media under similar conditions as described for in vitro fertilization.
Collection of blastocysts. Embryos at the blastocyst stage were obtained from F1 females, mated individually with F1 males as described above, by flushing the uterus 3.5 days p.c. with M2 medium supplemented with BSA (7 mg/ml).
Embryo transfer recipients. F1 (C57BL/6/CBA) females of at least 6 weeks of age were mated to vasectomized F1 males 1 day prior to embryo transfer. The morning after mating, females were checked for the presence of a vaginal plug and this was considered as day 0.5 of pseudopregnancy. A total of 40, 36 and 51 embryos (at early, non-expanded and fully expanded blastocyst stages, classification described in our previous study) (18) were transferred to the uteri of pseudopregnant females of groups A, B and C, respectively, on pseudopregnant day 3.5 according to standard procedures (33) . On day 10.5, females were sacrificed. Concepti were immediately collected and the developmental stage was estimated following the recommendations of Theiler et al. (23) . The placenta, yolk sac and embryos were mechanically separated. The placenta was cut in half, whereas the embryo was not divided. Both tissues (embryonic tissues and one half of placental tissue) were used for DNA methylation analysis. The other half of each placenta, reserved for expression analysis, was dropped in 250 ml of Trizol reagent (Invitrogen Life Technology, Cergy, France), snap-frozen and stored at 2808C until further use. The 21, 12 and 14 concepti from 4, 4 and 5 females were used for the experiments in groups A, B and C, respectively.
Methylation assays
DNA extraction. Nucleic acid isolation: genomic DNA was isolated from placental and fetal tissues by incubation with proteinase K (0.2 mg/ml) in lysis saline buffer following standard methods. The bisulphite conversion of genomic DNA (1 mg) and pyrosequencing analysis were performed as previously described (34, 62) . Table 1 lists the accession numbers and nucleotide positions of the analyzed regions, the PCR primers and annealing temperatures used, the size of the PCR products and the number of CpGs analyzed. Primers for PCR amplification and pyrosequencing were purchased from Biotez (Buch, Germany). Briefly, 50 ng of bisulphite converted DNA was added as template into PCR buffer with 1 mM MgCl 2 , 200 mM dNTP, 0.4 mM of each forward and reverse biotinylated primer and 2.0 U Platinum Taq polymerase (Invitrogen Life Technology). The PCR program consisted of a denaturing step of 4 min at 958C followed by 50 cycles of 30 s at 958C, 30 s at hybridization temperature (Table 1) and 20 s at 728C, with a final extension of 5 min at 728C. Purification of the PCR product with streptavidin Sepharosew HP beads (GE Healthcare, Uppsala, Sweden) and hybridization of the biotinylated PCR products and the sequencing primer were conducted following the PSQ96 sample preparation guide using a vacuum filtration sample transfer device (Pyrosequencing AB, Uppsala, Sweden). Sequencing was performed on a PSQ 96MA system with the PyroGold SQA reagent kit according to the manufacturer's instructions (Pyrosequencing AB). For one DMR, all the samples were analyzed inside the same experiment. The methylation analysis was performed in duplicate. The mean and SD were calculated using the individual methylation values (with n ¼ 21, n ¼ 12 and n ¼ 14 placentas and embryos, from groups A, B and C, respectively). Variables in the study groups were compared by using two-tailed t-tests, with P , 0.05 as the limit of significance.
Expression analysis of imprinted genes
Total RNA was extracted from a pool of five placental samples coming from at least 2 L with Trizol (Invitrogen Life Technology) according to the manufacturer's instructions. RT -PCR analysis of total DNase-treated RNA was carried out with random hexamer oligonucleotides in three independent reverse transcription reactions. The expression analyses were performed as previously described (21) . Sequences of the primers used for the determination of imprinted gene expression levels were those described by Varrault et al. (21) . The selection of appropriate housekeeping genes was performed with geNorm (26) . The level of expression of each imprinted gene (X) was normalized to the geometric mean of expression levels of three housekeeping genes (Gapdh, Mrpl32 and Tbp2), according to the formula: X/geometric mean (R1, R2, R3) ¼ 2 (Ct[X]-arithmetic mean [Ct(R1, Ct(R2), CT(R3)]) , where Ct is the threshold cycle, and R1, R2, R3 are the three housekeeping genes. Data were analyzed using a non-parametric KruskalWallis one-way analysis of variance with Benjamini -Hochberg correction (FDR 5%) for multiple testing, as implemented in the MeV 4.2 package (www.tm4.org), followed by post hoc paired comparisons.
Statistics
The x 2 test was used for the comparison of binary variables and continuous variables were compared using the independent Student's t-test, when appropriate. The significance level was set at 5% (P , 0.05).
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